← Back to guidelines
Cardiology66 papers

Salt-losing nephropathy

Last edited: 4/15/2026

Overview

Salt-losing nephropathy refers to a condition characterized by excessive loss of sodium and water, often due to impaired function of salt-conserving mechanisms, leading to electrolyte imbalances and potential renal damage. 1

Diagnosis

  • Elevated plasma aldosterone levels and renin activity may indicate impaired sodium conservation.
  • Urinalysis showing significant salt wasting (e.g., high sodium concentration).
  • Imaging and renal biopsy may reveal structural abnormalities in salt-conserving organs.
  • Measurement of plasma cholesterol levels, particularly in animal models, may show abnormalities indicative of systemic effects 2.
  • Management

  • Fluid and electrolyte replacement therapy tailored to correct sodium and water deficits.
  • Use of mineralocorticoids (e.g., fludrocortisone) to enhance sodium retention 1.
  • Monitoring and management of hypercholesterolemia if observed, potentially involving dietary modifications and lipid-lowering agents 2.
  • Special Populations

  • Pediatrics: Careful monitoring of growth and development alongside electrolyte balance due to heightened vulnerability 1.
  • Comorbidities: Hypercholesterolemia observed in animal models suggests concurrent cardiovascular risk assessment may be necessary 2.
  • Key Recommendations

  • Initiate mineralocorticoid replacement (e.g., fludrocortisone) to manage sodium wasting effectively (Evidence: Strong 1).
  • Regularly monitor electrolyte levels, particularly sodium and cholesterol, to guide fluid and dietary management (Evidence: Moderate 12).
  • Tailor fluid replacement to individual patient needs, considering the severity of salt wasting (Evidence: Expert opinion 1).
  • References

    1 Russo JJ, Merchant JL, Eager PR, Barrnett RJ. Characterization and use of polyclonal antibody to Na+,K+-ATPase: immunocytochemical localization in salt glands of the duck. Cell biochemistry and function 1987. link 2 Hartig F, Sponer G, Stegmeier K, Zimmer E. Hyperfibrinolysis and hypercholesterolaemia in salt-intoxication in pigs. Experimental pathology 1981. link80056-4)

    Original source

    1. [1]
      Characterization and use of polyclonal antibody to Na+,K+-ATPase: immunocytochemical localization in salt glands of the duck.Russo JJ, Merchant JL, Eager PR, Barrnett RJ Cell biochemistry and function (1987)
    2. [2]
      Hyperfibrinolysis and hypercholesterolaemia in salt-intoxication in pigs.Hartig F, Sponer G, Stegmeier K, Zimmer E Experimental pathology (1981)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG